Patent Law Weblog
recent posts
- Moderna Settles Patent Litigation with Arbutus et al.
- USPTO and DOJ Statement of Interest in Collision Communications: Another Thumb on the Scale in Favor of NPE Patent Plaintiffs
- Oasis Tooling, Inc. v. Siemens Industry Software Inc. (Fed. Cir. 2026)
- Why AI Will Not Take Over the World
- BioNTech Sues Moderna over mRNA Vaccine Technology
about
Category: Biotech/Pharma News
-
By Kevin Noonan The Indonesian health ministry agreed to resume supplying samples of H5N1 influenza virus to the World Health Organization, having received assurances from the agency that affordably flu vaccines would be made available to Indonesia and other poor countries, The New York Times reported Saturday. Earlier, Indonesia had suspended these supplies,…
-
By Jason Derry The Biotech Feature of the Month at PipelineReview.com provides an overview and discussion relating to the current state of biogenerics in the industry and marketplace. The Feature specifically discusses the major classes of biologics currently having branded products, including erythropoietin, somatotropin, interferon, granulocyte colony stimulating factor (G-CSF), insulin, and thrombolytics. …
-
By Kevin Noonan On first blush, it might appear that Indonesia’s decision to stop supplying avian influenza virus samples to global public health organizations, such as the U.N’s World Health Organization (WHO), is short-sighted or greedy or both (see "Virus for Sale"). However, the "rest of the story," at least in part, is…
-
By Kevin Noonan Indonesia is a country of over 200 million encompassing more than 17,000 islands in the Malay archipelago. It also has the largest number (81) of humans infected with the H5N1 strain of influenza virus (commonly called "bird flu"), with 63 fatalities. And until recently, it was a principle source of…
-
By Christopher P. Singer — In a January 24, 2007 press release, Roche announced that its multinational phase III study of Actemra (tocilizumab) for treatment of rheumatoid arthritis has met its endpoint. The study focused on patients with rheumatoid arthritis that had poor response to treatment with methotrexate. Over the course of the…
-
By Mark Chael — Meridian Biosciences, Inc. (Nasdaq: VIVO) of Cincinnati, OH recently announced that its subsidiary, Meridian Life Sciences, Inc., has manufactured an infectious inoculum of respiratory syncytial virus (RSV) to be used in human challenge studies of healthy volunteers. RSV is an enveloped RNA virus and the most common cause…
-
By Jason Derry — Research and Markets recently announced the availability of two new reports relating to the biotechnology industry: "Biotechnology in the United States" and "Biopartnering Strategies: Maximizing Returns from Biotechnology Deal-making." According to the Research and Markets website, "Biotechnology in the United States" provides data and analysis relating to trends and…
-
By Jason Derry — If you are interested in intellectual property issues involving nanotechnology, you might want to check out this paper published by the National Cancer Institute Alliance for Nanotechnology in Cancer. The paper was published in October 2006. Jason Derry, Ph.D., who graduated with honors from DePaul University College of Law,…
Patent Docs 